Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes, SGLT2 inhibitors may reduce the chance of atrial arrhythmia returning after catheter ablation, especially in patients with heart failure.
Yes, sepsis survivors often face long-term cognitive, physical, and psychological problems known as post-sepsis syndrome, with impairments persisting for months to years.
Yes, Hadlima (adalimumab) is FDA-approved for treating moderately to severely active rheumatoid arthritis in adults.
In China, sepsis care quality indicators include timely antibiotic administration, blood culture collection, lactate measurement, and fluid resuscitation, as outlined in a Delphi…
Yes, sinomenine reduces arthritis markers in animal studies for rheumatoid arthritis, as shown by meta-analyses and individual rodent studies.
Patients with rheumatoid arthritis have a higher risk of shingles compared to the general population, with a pooled proportion of about 6% and a 30% increased risk.
RNA methylation, especially m6A, is increased in rheumatoid arthritis and may drive synovitis by altering gene expression in joint cells, with potential as a biomarker and…
Early research suggests plant-derived extracellular vesicles may reduce inflammation in rheumatoid arthritis, but human studies are lacking.
Yes, Lazcluze (lazertinib) is FDA-approved for first-line treatment of locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R mutations, in combination…
Scientists are improving flu vaccines by combining them with other vaccines, using intranasal delivery, and engineering virus-like particles to trigger broader immune responses.
Yes, pembrolizumab alone is a standard first-line treatment for advanced NSCLC with PD-L1 ≥50%, with real-world data showing mean overall survival of 21 months and 29% survival…
Yes, coadministering the high-dose flu shot and RSV vaccine is safe and works well for seniors, though the RSV immune response may be slightly lower.
Yes, a 2026 meta-analysis found that early-day immune checkpoint inhibitor administration improves overall survival in advanced solid tumors, including non-small cell lung cancer.
Yes, advanced liver fibrosis (stage F3-F4) significantly increases the risk of developing hepatocellular carcinoma compared to no or mild fibrosis, with higher cumulative…
Yes, Auvelity (dextromethorphan/bupropion) is FDA-approved for treating major depressive disorder in adults.
No, JNJ-42165279 did not improve depression in a clinical trial of people whose SSRI/SNRI was not working well enough.
Lab findings often don't translate to real-world HCC care due to tumor heterogeneity, racial disparities, and lack of validated biomarkers for routine use.
Yes, text-message CBT (CBT-txt) significantly reduces depressive symptoms in young adults with major depressive disorder, based on multiple randomized trials.
Inpatient rehabilitation for MS includes gait training, robot-assisted therapy, strength, balance, and aerobic exercises, all showing mobility and fatigue benefits.
The incidence of Multiple Sclerosis in women of childbearing age has increased by 48% from 1990 to 2021, according to a global burden of disease study.
Yes, advanced liver scarring (fibrosis/cirrhosis) significantly raises your risk of developing hepatocellular carcinoma, especially in MASLD patients.
Yes, both aerobic and strength training can reduce fatigue in people with multiple sclerosis, with studies showing similar benefits from each modality.
Yes, Black patients have worse survival after liver transplant for hepatocellular carcinoma, with a 27% higher risk of death compared to White patients.
CAR-T cell therapies are not yet approved for MS but are being tested in clinical trials, with early results showing safety and potential benefit.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.